ArticleCancers2025

Optimising Cancer Medicine in Clinical Practices: Are Neoadjuvant and Adjuvant Immunotherapies Affordable for Cancer Patients in Low- and Middle-Income Countries?

Rashidul Alam MahumudPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.